Zobrazeno 1 - 10
of 29
pro vyhledávání: '"NIKE group"'
Autor:
Giuseppe Fanciulli, Sergio Di Molfetta, Andrea Dotto, Tullio Florio, Tiziana Feola, Annamaria Colao, Antongiulio Faggiano, NIKE Group, Manuela Albertelli, Barbara Altieri, Luigi Barrea, Filomena Bottiglieri, Severo Campione, Federica de Cicco, Alessandra Dicitore, Diego Ferone, Francesco Ferraù, Erika Grossrubatscher, Marco Gallo, Elisa Giannetta, Federica Grillo, Elia Guadagno, Valentina Guarnotta, Andrea M. Isidori, Andrea Lania, Andrea Lenzi, Fabio Lo Calzo, Pasquale Malandrino, Erika Messina, Roberta Modica, Giovanna Muscogiuri, Genoveffa Pizza, Riccardo Pofi, Giulia Puliani, Carmen Rainone, Paola Razzore, Laura Rizza, Manila Rubino, Rosa Maria Ruggieri, Emilia Sbardella, Franz Sesti, Mary Anna Venneri, Giovanni Vitale, Maria Chiara Zatelli
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/c1fdb504ea24461b8e3ba43bf4dd6d1b
Autor:
Manuela Albertelli, Federica Grillo, Fabio Lo Calzo, Giulia Puliani, Carmen Rainone, Annamaria Anita Livia Colao, Antongiulio Faggiano, NIKE group, Barbara Altieri, Luigi Barrea, Filomena Bottiglieri, Severo Campione, Federica De Cicco, Sergio Di Molfetta, Alessandra Dicitore, Carlotta Dolci, Tiziana Feola, Giuseppe Fanciulli, Diego Ferone, Francesco Ferraù, Marco Gallo, Elisa Giannetta, Erika Grossrubatscher, Elia Guadagno, Valentina Guarnotta, Andrea M. Isidori, Andrea Lania, Andrea Lenzi, Pasquale Malandrino, Erika Messina, Roberta Modica, Giovanna Muscogiuri, Luca Pes, Genoveffa Pizza, Riccardo Pofi, Paola Razzore, Laura Rizza, Manila Rubino, Rosa Maria Ruggieri, Emilia Sbardella, Franz Sesti, Mary Anna Venneri, Giovanni Vitale, Maria Chiara Zatelli
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
During the 5th NIKE (Neuroendocrine tumors Innovation in Knowledge and Education) meeting, held in Naples, Italy, in May 2019, discussions centered on the understanding of pathology reports of gastroenetropancreactic neuroendocrine neoplasms. In part
Externí odkaz:
https://doaj.org/article/4dd7112e36924371a652f68643be1b0a
Autor:
Ruggeri, R M, Benevento, E, De Cicco, F, Fazzalari, B, Guadagno, E, Hasballa, I, Tarsitano, M G, Isidori, A M, Colao, A, Faggiano A, NIKE group, Guarnotta, V
Purpose Neuroendocrine neoplasms can occur as part of inherited disorders, usually in the form of well-differentiated, slow-growing tumors (NET). The main predisposing syndromes include: multiple endocrine neoplasias type 1 (MEN1), associated with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1acd31783eb6456007e3bb26b902e163
https://hdl.handle.net/10447/582573
https://hdl.handle.net/10447/582573
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sergio, Di Molfetta, Tiziana, Feola, Giuseppe, Fanciulli, Tullio, Florio, Annamaria, Colao, Antongiulio, Faggiano, Nike Group
Lung carcinoids are well-differentiated and low-/intermediate-grade neuroendocrine neoplasms of the lung. Given their relative rarity, and the paucity of data available from prospective studies, no global consensus exists on the systemic treatment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112ddf827e71b0563aad6e459b1564d2
http://hdl.handle.net/11567/1070678
http://hdl.handle.net/11567/1070678
Autor:
Pasqualino, Malandrino, Rossella, Mazzilli, Giulia, Puliani, Sergio, Di Molfetta, Gabriella, Pugliese, Soraya, Olana, Anna Maria, Colao, Antongiulio, Faggiano, On Behalf Of The Nike Group
Publikováno v:
Cancers. 15:115
Peptide receptor radionuclide therapy (PRRT), also called radioligand therapy, is an effective antitumoral treatment in patients with neuroendocrine neoplasm (NEN). It improves the patient’s health-related quality of life (HRQoL), which is evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ba3eb2d996e0046b4e2fbcd715bfe86
https://doi.org/10.3390/cancers15010115
https://doi.org/10.3390/cancers15010115
Autor:
Ruggeri, R. M., Benevento, E., De Cicco, F., Fazzalari, B., Guadagno, E., Hasballa, I., Tarsitano, M. G., Isidori, A. M., Colao, A., Faggiano, A., on behalf of NIKE Group, Aini, I, Albertelli, M, Alessi, Y, Altieri, B, Antonini, S, Barrea, L, Birtolo, F, Campolo, F, Cannavale, G
Publikováno v:
Journal of Endocrinological Investigation; Feb2023, Vol. 46 Issue 2, p213-234, 22p
Autor:
Giuseppe Fanciulli, Sergio Di Molfetta, Andrea Dotto, Tullio Florio, Tiziana Feola, Annamaria Colao, Antongiulio Faggiano, NIKE Group, Manuela Albertelli, Barbara Altieri, Luigi Barrea, Filomena Bottiglieri, Severo Campione, Federica de Cicco, Alessandra Dicitore, Diego Ferone, Francesco Ferraù, Erika Grossrubatscher, Marco Gallo, Elisa Giannetta, Federica Grillo, Elia Guadagno, Valentina Guarnotta, Andrea M. Isidori, Andrea Lania, Andrea Lenzi, Fabio Lo Calzo, Pasquale Malandrino, Erika Messina, Roberta Modica, Giovanna Muscogiuri, Genoveffa Pizza, Riccardo Pofi, Giulia Puliani, Carmen Rainone, Paola Razzore, Laura Rizza, Manila Rubino, Rosa Maria Ruggieri, Emilia Sbardella, Franz Sesti, Mary Anna Venneri, Giovanni Vitale, Maria Chiara Zatelli
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, Vol 12 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb20657b25e663ed2300d96baf7abf4
http://europepmc.org/articles/PMC8253222
http://europepmc.org/articles/PMC8253222
Autor:
Zatelli, Maria Chiara, Fanciulli, Giuseppe, Malandrino, Pasqualino, NIKE GROUP: Albertelli M, Arvat E, Baldelli R, Berruti A, Bianchi A, Bodei L, Botti G, Corcione F, Daví MV, Delle Fave G, De Marinis L, Di Sarno A, Dicitore A, Fazio N, Ferolla P, Ferone D, Filice A, Gallo M, Giordano C, Giuffrida D, Guarnotta V, Lania A, Lastoria S, Logoluso F, Loli P, Manzoni M, Marchetti M, Martini C, Messina E, Modica R, Motta C, Papotti M, Partelli S, Persico G, Pia A, Piovesan A, Pontecorvi A, Razzore P, Rota F, Scavuzzo F, Sciammarella C, Vitale G., RAMUNDO, VALERIA, FAGGIANO, ANTONGIULIO, COLAO, ANNAMARIA, DE ROSA, GAETANO
Publikováno v:
Endocrine-Related Cancer. 23:R173-R183
Medical treatment of neuroendocrine tumours (NETs) has drawn a lot of attention due to the recent demonstration of efficacy of several drugs on progression-free survival, including somatostatin analogs, small tyrosine kinase inhibitors and mTOR inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6655e53dd15554bad67e602ff7f2473
https://doi.org/10.1530/erc-15-0413
https://doi.org/10.1530/erc-15-0413
Autor:
Erika, Grossrubatscher, Giuseppe, Fanciulli, Luca, Pes, Franz, Sesti, Carlotta, Dolci, Federica, de Cicco, Annamaria, Colao, Antongiulio, Faggiano, Nike Group
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 3507, p 3507 (2020)
Journal of Clinical Medicine, Vol 9, Iss 3507, p 3507 (2020)
Effective treatment options in advanced/progressive/metastatic medullary thyroid carcinoma (MTC) are currently limited. As in other neuroendocrine neoplasms (NENs), peptide receptor radionuclide therapy (PRRT) has been used as a therapeutic option in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::456db968e760c9355613834a4d935eaf
https://pubmed.ncbi.nlm.nih.gov/33138305
https://pubmed.ncbi.nlm.nih.gov/33138305